These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6862052)

  • 21. Studies of glucagon secretion in pancreatectomized patients.
    Muller WA; Brennan MF; Tan MH; Aoki TT
    Diabetes; 1974 Jun; 23(6):512-6. PubMed ID: 4834290
    [No Abstract]   [Full Text] [Related]  

  • 22. Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis.
    Keller U; Szöllösy E; Varga L; Gyr K
    Dig Dis Sci; 1984 Sep; 29(9):853-7. PubMed ID: 6381002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The dynamic property of glucagon secretion in response to blood glucose--analysis with the aid of the control theory using an artificial endocrine pancreas].
    Yagi T
    Nihon Naibunpi Gakkai Zasshi; 1985 Feb; 61(2):69-79. PubMed ID: 3891432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion.
    Hermansen K; Schmitz O; Boye N; Christensen CK; Christiansen JS; Alberti KG; Orskov H; Mogensen CE
    Metabolism; 1988 Jul; 37(7):640-4. PubMed ID: 3290622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
    Katsura M
    Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1276-88. PubMed ID: 3542595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH; Fajans SS; Smith MJ; Polonsky KS; Bell GI; Halter JB
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db-db).
    Laube H; Fussgänger RD; Maier V; Pfeiffer EF
    Diabetologia; 1973 Oct; 9(5):400-2. PubMed ID: 4773201
    [No Abstract]   [Full Text] [Related]  

  • 28. Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.
    Luyckx AS; Mendoza E; Lefebvre PJ
    Diabetologia; 1981 Oct; 21(4):376-82. PubMed ID: 7026333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy.
    Campbell LV; Kraegen EW; Lazarus L
    Br Med J; 1977 Dec; 2(6101):1527-9. PubMed ID: 589316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 31. Circulating insulin inhibits glucagon secretion induced by arginine in type 1 diabetes.
    Oskarsson PR; Lins PE; Ahré B; Adamson UC
    Eur J Endocrinol; 2000 Jan; 142(1):30-4. PubMed ID: 10633218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of pancreatic alpha cell function in normal and diabetic subjects.
    Unger RH; Aguilar-Parada E; Müller WA; Eisentraut AM
    J Clin Invest; 1970 Apr; 49(4):837-48. PubMed ID: 4986215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier J; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha cell function in diabetes mellitus.
    Gerich JE
    Metabolism; 1976 Nov; 25(11 Suppl 1):1513-6. PubMed ID: 790098
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of acute exercise on pancreatic endocrine function in subjects with type 2 diabetes.
    Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK; Solomon TP
    Diabetes Obes Metab; 2015 Feb; 17(2):207-10. PubMed ID: 25406646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine function of the pancreas in cystic fibrosis: evidence for an impaired glucagon and insulin response following arginine infusion.
    Stahl M; Girard J; Rutishauser M; Nars PW; Zuppinger K
    J Pediatr; 1974 Jun; 84(6):821-4. PubMed ID: 4826615
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of glucagon secretion of the diabetic pancreas in vitro [proceedings].
    Matschinsky FM; Pagliara AS
    Metabolism; 1976 Nov; 25(11 Suppl 1):1517. PubMed ID: 135912
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro inhibition of pancreatic glucagon secretion by diphenylhydantoin.
    Gerich JE; Charles MA; Levin SR; Forsham PH; Grodsky GM
    J Clin Endocrinol Metab; 1972 Dec; 35(6):823-4. PubMed ID: 4634482
    [No Abstract]   [Full Text] [Related]  

  • 39. Abnormal secretion of insulin and glucagon by the in vitro perfused pancreas of the genetically diabetic Chinese hamster.
    Frankel BJ; Gerich JE; Hagura R; Fanska RE; Gerritsen GC; Grodsky GM
    J Clin Invest; 1974 Jun; 53(6):1637-46. PubMed ID: 4830228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of insulin on the exaggerated glucagon response to arginine stimulation in diabetes mellitus.
    Raskin P; Aydin I; Unger RH
    Diabetes; 1976 Mar; 25(3):227-9. PubMed ID: 1254112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.